PCN188 - ASSESSING THE ROBUSTNESS OF A COST-EFFECTIVENESS ANALYSIS OF LENVATINIB VERSUS SORAFENIB IN UNRESECTABLE HEPATOCELLULAR CARCINOMA IN JAPAN
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.270
https://www.valueinhealthjournal.com/article/S1098-3015(18)33570-8/fulltext
Title :
PCN188 - ASSESSING THE ROBUSTNESS OF A COST-EFFECTIVENESS ANALYSIS OF LENVATINIB VERSUS SORAFENIB IN UNRESECTABLE HEPATOCELLULAR CARCINOMA IN JAPAN
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)33570-8&doi=10.1016/j.jval.2018.09.270
First page :
Section Title :
Open access? :
No
Section Order :
2065